Pre-cancer of the cervix means some cells on the surface of your cervix have started to look abnormal under a microscope, but they haven’t become cancer. These changes are called cervical intraepithelial neoplasia, or CIN, and they’re graded on a scale from 1 to 3 based on how deeply the abnormal cells extend into the cervical lining. The key distinction: precancerous cells stay on the surface. They only become cancer if they break through the deeper boundary layer of tissue beneath, which can take years or may never happen at all.
How Precancerous Grades Differ
The cervix is lined with layers of cells, and the CIN grading system reflects how much of that lining is affected. CIN 1 means abnormal cells are found only in the bottom third of the lining. This is considered low-grade and is the mildest form. CIN 2 and CIN 3 are both classified as high-grade: CIN 2 involves more than the lower third, and CIN 3 means abnormal cells span nearly the full thickness of the lining.
These grades matter because they predict very different outcomes. In younger women, CIN 2 regresses on its own roughly 88% of the time. CIN 3 is more stubborn, with only about 29% of cases regressing without treatment in that same age group. In a study tracking young women with high-grade changes, none developed invasive cancer during the follow-up period, but CIN 3 persisted without improving in 71% of cases, which is why treatment is typically recommended for high-grade lesions rather than waiting.
Why Precancerous Changes Happen
Nearly all cervical precancer is caused by persistent infection with high-risk strains of human papillomavirus (HPV). There are about 12 high-risk HPV types, but two of them, HPV 16 and HPV 18, are responsible for most HPV-related cancers. HPV is extremely common, and most infections clear on their own within a year or two. Precancerous changes develop when the virus lingers for years, gradually pushing cervical cells toward abnormal growth.
Several factors increase the chance that an HPV infection will persist long enough to cause precancer. These include smoking, a weakened immune system (from conditions like HIV or from immunosuppressive medications), and being infected with a particularly aggressive HPV type. Having HPV 16 or 18 specifically raises the risk compared to other high-risk strains.
Why You Won’t Feel It
Precancerous changes in the cervix almost never cause symptoms. There’s no pain, no unusual bleeding, no discharge that would tip you off. The first sign is almost always an abnormal result on a screening test. This is exactly why routine cervical screening exists: it catches changes that are invisible to you but clearly visible under a microscope, giving you a window to treat them before they ever become cancer.
How Precancer Is Found
Cervical screening is the entry point. Current guidelines from the American Cancer Society recommend starting screening at age 25 and continuing until at least age 65. The preferred approach is an HPV test every five years, though a Pap test alone every three years is an alternative if HPV testing isn’t available.
If your screening result comes back abnormal, the next step is usually a colposcopy. During this procedure, a doctor uses a magnifying instrument to examine your cervix up close. A dilute vinegar solution is applied to the cervix, which causes precancerous cells to turn white, making them visible. The doctor then takes small tissue samples (biopsies) from any suspicious areas. Those samples go to a lab, where a pathologist examines them and assigns a CIN grade. The entire colposcopy takes about 15 to 20 minutes and feels similar to a Pap test, though the biopsies can cause brief cramping or a pinching sensation.
Treatment for High-Grade Changes
Low-grade changes (CIN 1) are usually monitored rather than treated, since most resolve on their own. High-grade changes (CIN 2 and CIN 3) are more likely to require treatment, especially in women over 25.
The most common treatment is a loop electrosurgical excision procedure, often called LEEP. This is done in a doctor’s office with local anesthesia. A thin wire loop carrying an electrical current removes the affected tissue from the cervix. The other main option, cold knife conization, is a surgical procedure done under general anesthesia that cuts out a cone-shaped piece of cervical tissue. It’s typically reserved for cases where the doctor needs a cleaner tissue sample or when the abnormal area extends into the cervical canal.
Both procedures are highly effective. In a review of 447 cases, the rate of residual or recurrent precancer after either LEEP or cold knife conization was just 2.9%. LEEP is generally preferred because it’s less invasive and causes fewer complications, though it can sometimes fragment the tissue sample, making it harder for the lab to evaluate the edges of the removed tissue.
What Recovery Looks Like
After a LEEP, you can go back to work or school within one to two days. Full healing of the cervix takes four to six weeks. During that time, mild cramping for a few days is normal, along with vaginal discharge that may be greenish-yellow or brownish-black for one to three weeks. Some of this discharge can have an unpleasant smell, which is expected.
During the four-week healing period, you’ll need to avoid vaginal intercourse, tampons, baths, and swimming. Exercise should be limited for at least the first week, and heavy activity should be avoided for the first 48 hours. Showers are fine throughout recovery.
How the HPV Vaccine Has Changed the Picture
The HPV vaccine has dramatically reduced cervical precancer rates. CDC data from 2008 to 2022 shows that among screened women aged 20 to 24 (the group most likely to have been vaccinated), high-grade precancer rates dropped by 80%. That’s not a small dip. It represents a fundamental shift in how common these diagnoses are in vaccinated populations. The vaccine is most effective when given before any exposure to HPV, which is why it’s recommended in the preteen years, but it provides benefit up to age 26 and in some cases up to 45.
For those who are already past vaccination age or who have already been diagnosed with precancerous changes, routine screening remains the most important tool. Catching CIN early and treating it when needed prevents the vast majority of cervical cancers, which is why cervical cancer rates have fallen steadily in countries with strong screening programs.